---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-012761"
form_type: "8-K"
ticker: "CRVO"
cik: "0001053691"
company_name: "CervoMed Inc."
filed_at: "2024-04-23T23:59:59+00:00"
generated_at: "2026-06-03T11:14:11.602058+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "low"
source: SEC EDGAR
---

# CervoMed reports 8,253,741 shares outstanding as of April 22, 2024

## Summary
- Share count disclosed as 8,253,741 shares of common stock outstanding as of April 22, 2024.
- No other material updates or events reported in the filing.
- The corporate presentation made available on the company's website contains no new clinical or financial data disclosed in the filing.

## SEC filing metadata
- accession: 0001437749-24-012761
- form_type: 8-K
- ticker: CRVO
- cik: 0001053691
- company_name: CervoMed Inc.
- filed_at: 2024-04-23T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: low
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1053691/000143774924012761/0001437749-24-012761-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1053691/000143774924012761/crvo20240422_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-012761
- JSON: https://secwatch.observer/filing/0001437749-24-012761.json
- Plain text: https://secwatch.observer/filing/0001437749-24-012761.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.